The research lab led by Joseph Bondy-Denomy at UCSF focuses on understanding how bacteria resist infection by bacteriophages, which are viruses that specifically target bacteria. By employing advanced genetic and proteomic techniques, the lab aims to identify bacterial vulnerabilities that could be exploited to improve phage therapy, especially in the context of antibiotic resistance. This work is particularly relevant in the fight against antibiotic-resistant infections, as it seeks to develop new therapeutic strategies that harness the power of these viral predators.

Dr. Alexander D Johnson's lab at UCSF focuses on understanding the genetic mechanisms of the fungal pathogen Candida albicans, particularly how it can switch between two different cell types to thrive in various environments within the human body. This research is crucial because Candida albicans can cause serious infections, especially in people with weakened immune systems. By studying the white-opaque switching mechanism, the lab aims to uncover how this process helps the fungus adapt and survive in its host.

Dr. Kole Roybal's lab at UCSF focuses on developing innovative engineered T cell therapies for cancer treatment, particularly targeting malignant mesothelioma. The lab is pioneering the use of combination antigen sensing technologies to enhance the precision and effectiveness of T cell activation against solid tumors. Additionally, they are working on novel imaging techniques that utilize engineered T cells for better monitoring of tumor response to therapies, contributing to safer and more effective cancer treatments.

Dr. Raul Andino's lab at UCSF focuses on understanding how enteroviruses, which can cause severe illnesses in children, infect cells and tissues. The research utilizes advanced techniques in genomics and single-cell analysis to explore how these viruses replicate and how the body responds to them. The ultimate aim is to improve our understanding of the pathogenesis of these infections, leading to the development of better vaccines and antiviral therapies.

Dr. Suzanne Noble's research lab at UCSF focuses on understanding how certain fungi, particularly Candida species, colonize the human body without causing disease and how they can become pathogenic. The lab investigates the molecular mechanisms behind gut colonization by Candida albicans and skin colonization by Candida auris, helping to shed light on the transitions from harmless commensalism to pathogenicity. This research is crucial for developing strategies to manage fungal infections, especially those caused by drug-resistant strains.

Dr. Angela Marie Phillips' lab at UCSF focuses on how antibodies evolve and adapt to combat the SARS-CoV-2 virus. The research explores the physical properties of antibodies and how these influence their effectiveness in attaching to diverse viral variants. By understanding these mechanisms, the lab aims to pave the way for designing better antibodies that can protect against current and future viruses.

Dr. Anita Sil's lab at UCSF focuses on studying how the fungus Histoplasma capsulatum changes its form and behavior in response to temperature, which is crucial for its ability to infect humans. Their research aims to uncover the molecular mechanisms behind this transformation, including the role of specific proteins that help the fungus evade the immune system. By exploring these biological processes, the lab hopes to enhance our understanding of fungal infections and find new strategies for treating them.